Resistance training may not only help to build muscle in older people, it may also be warding off type 2 diabetes, a new study demonstrates.

Fully half of U.S. patients hospitalized for coronary artery disease now have an LDL cholesterol level of 100 mg/dL or less on admission.

The safety of inhaled insulin is holding up at 2 years in an ongoing study, with adverse pulmonary effects being small, occurring early, and proving reversible on cessation of the drug

Switching to a low glycemic index (GI) diet from a high GI diet can result in improvements in insulin sensitivity, and may thereby lower the risk of type 2 diabetes in overweight or obese individuals with impaired glucose tolerance.

A nationwide survey of adults over the age of 40 has found that only 41% say they regularly take aspirin.

W. C. Willett, MD Department of Nutrition, Harvard School of Public Health, has reviewed the latest studies of low carbohydrate food choices and answers the question of Low-Carbohydrate Diets: A Place In Health Promotion?

UCSF’s Dr. Jeffrey Bluestone and Columbia University’s Dr. Kevan Herold share their study, demonstrating for the first time that antibody therapy could essentially stop diabetes in its tracks 1 year later if used early after type 1 diabetes diagnosis.

Long-term all-cause mortality rates among people diagnosed with celiac disease in childhood are threefold higher than population mortality rates.

Vitamin D does not seem to be associated with glycemic control in subjects with diabetes mellitus, according to findings presented at the American Association of Clinical Endocrinologists 16th Annual Meeting and Clinical Congress (AACE)

Once-daily treatment with liraglutide, an investigational drug injectable agent for type 2 diabetes, improved beta cell function, by 114% and increased first phase insulin secretion by 124%